BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36329130)

  • 1. Mast cell stabilization: new mechanism underlying the therapeutic effect of intense pulsed light on rosacea.
    Jiang P; Liu Y; Zhang J; Liu Y; Li M; Tao M; Zhang Y; Tang Z; Liu W; Xu Y
    Inflamm Res; 2023 Jan; 72(1):75-88. PubMed ID: 36329130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.
    Zhang J; Jiang P; Sheng L; Liu Y; Liu Y; Li M; Tao M; Hu L; Wang X; Yang Y; Xu Y; Liu W
    Front Immunol; 2021; 12():609615. PubMed ID: 34322115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin blocks mast cells and prevents rosacea like inflammation.
    Choi JE; Werbel T; Wang Z; Wu CC; Yaksh TL; Di Nardo A
    J Dermatol Sci; 2019 Jan; 93(1):58-64. PubMed ID: 30658871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea.
    Muto Y; Wang Z; Vanderberghe M; Two A; Gallo RL; Di Nardo A
    J Invest Dermatol; 2014 Nov; 134(11):2728-2736. PubMed ID: 24844861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative skincare trial of intense pulsed light followed by the phyto-corrective mask, phyto-corrective gel, and resveratrol BE for decreasing post-procedure downtime and improving procedure outcomes in patients with rosacea.
    Barbarino SC; Bucay VW; Cohen JL; Gold MH
    J Cosmet Dermatol; 2022 Sep; 21(9):3759-3767. PubMed ID: 35765796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light-emitting diodes downregulate cathelicidin, kallikrein and toll-like receptor 2 expressions in keratinocytes and rosacea-like mouse skin.
    Lee JB; Bae SH; Moon KR; Na EY; Yun SJ; Lee SC
    Exp Dermatol; 2016 Dec; 25(12):956-961. PubMed ID: 27315464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel.
    Coda AB; Hata T; Miller J; Audish D; Kotol P; Two A; Shafiq F; Yamasaki K; Harper JC; Del Rosso JQ; Gallo RL
    J Am Acad Dermatol; 2013 Oct; 69(4):570-7. PubMed ID: 23871720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-pulsed 1064-nm Nd: YAG laser ameliorates LL-37-induced rosacea-like skin lesions through promoting collagen remodeling in BALB/c mice.
    Kim M; Kim J; Jeong SW; Jo H; Park HJ
    Lasers Med Sci; 2018 Feb; 33(2):393-397. PubMed ID: 29256058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide ameliorates rosacea-like skin inflammation and suppresses NF-κB activation in keratinocytes.
    Chen M; Xie H; Chen Z; Xu S; Wang B; Peng Q; Sha K; Xiao W; Liu T; Zhang Y; Li J; Deng Z
    Biomed Pharmacother; 2019 Aug; 116():109011. PubMed ID: 31132668
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Roh KB; Ryu DH; Cho E; Weon JB; Park D; Kweon DH; Jung E
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33256158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models.
    Thibaut de Ménonville S; Rosignoli C; Soares E; Roquet M; Bertino B; Chappuis JP; Defoin-Platel/Chaussade C; Piwnica D
    Dermatol Ther (Heidelb); 2017 Jun; 7(2):213-225. PubMed ID: 28243927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine is a novel therapeutic approach for rosacea.
    Li J; Yuan X; Tang Y; Wang B; Deng Z; Huang Y; Liu F; Zhao Z; Zhang Y
    Int Immunopharmacol; 2020 Feb; 79():106178. PubMed ID: 31918061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color.
    Kawana S; Ochiai H; Tachihara R
    Dermatol Surg; 2007 Apr; 33(4):449-54. PubMed ID: 17430379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of mast cell infiltration in an LL-37-induced rosacea mouse model using topical brimonidine tartrate 0.33% gel.
    Kim M; Kim J; Jeong SW; Jo H; Woo YR; Park HJ
    Exp Dermatol; 2017 Nov; 26(11):1143-1145. PubMed ID: 28500634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of cathelicidin by direct activation of protease-activated receptor 2: possible implications on the pathogenesis of rosacea.
    Kim JY; Kim YJ; Lim BJ; Sohn HJ; Shin D; Oh SH
    Yonsei Med J; 2014 Nov; 55(6):1648-55. PubMed ID: 25323904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of MrgprB2 in Rosacea-Like Inflammation in Mice: Modulation by β-Arrestin 2.
    Roy S; Alkanfari I; Chaki S; Ali H
    J Invest Dermatol; 2022 Nov; 142(11):2988-2997.e3. PubMed ID: 35644498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supramolecular salicylic acid ameliorates rosacea-like eruptions by suppressing NLRP3-mediated inflammasome activation in mice.
    Wang J; Sun Y; Chen L; Wang Y; Shi D; Wu Y; Gao X
    Int Immunopharmacol; 2023 May; 118():110057. PubMed ID: 36989903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent Demodex infection contributes to intense pulsed light aggravated rosacea: cases serial.
    Wang P; Zhang L; Shi L; Yuan C; Zhang G; Wang X
    J Cosmet Laser Ther; 2019; 21(3):163-165. PubMed ID: 30040520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label study assessing the efficacy and tolerability of topical skin care and sun protection alone and in combination with intense pulsed light therapy.
    Deaver Peterson J; Katz TM
    J Cosmet Dermatol; 2019 Dec; 18(6):1758-1764. PubMed ID: 31017734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of short-pulsed intense pulsed light and pulsed dye laser to treat rosacea.
    Kim BY; Moon HR; Ryu HJ
    J Cosmet Laser Ther; 2019 Aug; 21(5):291-296. PubMed ID: 30285506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.